International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
The tumor microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Comprising a complex network of cellular components, extracellular matrix, soluble factors, and signaling molecules, the TME influences tumor behavior and shapes the patient's clinical trajectory. Over recent years, advancements in high-throughput technologies and bioinformatics have provided unprecedented opportunities to unravel the intricate dynamics within the TME, offering insights into mechanisms driving tumorigenesis and identifying potential therapeutic targets. By holistically deciphering the TME using both mechanistic and bioinformatics approaches, researchers can pave the way for more personalized and effective cancer therapies. This special issue seeks to showcase cutting-edge research and reviews focused on unveiling the intricacies of the TME. By diving deep into mechanistic studies and utilizing powerful bioinformatics tools, we aim to provide a comprehensive understanding of the interplay between cancer cells and their surrounding milieu, setting the stage for transformative breakthroughs in oncology. Sub-themes: 1. Cellular Components of the TME: Detailed exploration of the diverse cellular actors, such as cancer-associated fibroblasts, tumor-associated macrophages, and immune cells, and their role in shaping the tumor landscape. 2. Extracellular Matrix and Tumor Stiffness: Investigating how changes in the stiffness and composition of the extracellular matrix influence tumor progression and metastasis. 3. Mechanistic Insights into Immune Evasion: Understanding the strategies employed by tumors to evade immune surveillance within the TME. 4. Bioinformatics Analysis of TME Heterogeneity: Utilizing computational tools to delineate the heterogeneous makeup of the TME and its implications for tumor progression. 5. Metabolic Reprogramming in the TME: Exploring the metabolic shifts within the TME and their role in supporting tumor growth and survival. 6. Signaling Pathways in the TME: Elucidating key signaling pathways active within the TME, driving cancer progression, and offering potential therapeutic targets. 7. Integrative Multi-omics Analysis of the TME: Leveraging genomics, transcriptomics, proteomics, and metabolomics to provide a holistic view of the TME's dynamics. 8. Therapeutic Strategies Targeting the TME: Highlighting innovative therapeutic approaches that specifically target components of the TME, aiming to circumvent resistance and enhance treatment efficacy. With this special issue, we invite oncologists, biologists, bioinformaticians, and researchers from interdisciplinary fields to contribute their expertise, collectively illuminating the multifaceted world of the tumor microenvironment and its critical role in the cancer paradigm.